is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business.

I am pleased to announce that Sotera Health delivered another year of top-line growth in 2024,” said Mr. Petras. “We expect full-year revenues will be approximately $1.1 billion, representing growth ...

A live webcast of Mr. Petras’ presentation and accompanying materials may be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of ...

Expand Energy started with Outperform rating at J.P. Morgan, citing large-scale exposure to natural gas as the largest producer in the U.S. and the trend of growing natgas demand.

He cut Federated Hermes ( NYSE: FHI) to Neutral from Overweight, partly due to lost market share in money funds and partly ...

Ollie's Bargain Outlet Holdings (NASDAQ:OLLI) was one of the biggest gainers in the consumer sector on Thursday after J.P. Morgan added the stock to its Analyst Focus List on its view the retailer ...

Expand Energy (NASDAQ:EXE) +2.7% in Thursday's trading to an all-time high of $108.83 as J.P. Morgan launches coverage with an Outperform rating and $112 price target, citing large-scale exposure ...

I detail why it will likely beat the Nasdaq 100 in 2025.

Kymera Therapeutics (KYMR) stock surged as the company outlined its 2025 outlook at the J.P. Morgan Healthcare Conference. Read more here.

CLEVELAND, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ ... Petras, Jr. will present at the 43rd Annual J.P. Morgan Healthcare ...

J.P. Morgan raised its recommendation on LegalZoom to Overweight from Underweight, and increased the price target to $9.00 from $8.00. 2025 adjusted EBITDA is now estimated to come at $167M ...